FilingReader Intelligence
Kaygee Investments consolidates Ipca Laboratories holdings post-merger
August 21, 2025 at 07:29 AM UTC•By FilingReader AI
Kaygee Investments Private Limited merged wholly-owned subsidiaries Paschim Chemicals and Mexin Medicaments into itself, consolidating all assets including investments in Ipca Laboratories.
The merger maintains Kaygee's 25.49% stake in Ipca Laboratories, with holdings now held directly rather than through subsidiaries.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:IPCALAB•Bombay Stock Exchange
News Alerts
Get instant email alerts when Ipca Laboratories publishes news
Free account required • Unsubscribe anytime